Latest Articles
-
Oracle’s Debt Fueled Cloud Surge Buys It Time
Oracle's Q3 earnings beat expectations with 44% cloud growth, validating its AI strategy. Yet, massive debt and negative cash flow reveal a high-risk gamble.
business -
Every Screen a Battleground The NFL Rights Auction Looms
CBS and Fox prepare for a costly NFL rights war as streaming giants loom. The NBA's own digital gambit signals the end of traditional sports broadcasting.
sports -
The Cardiovascular Trial Testing a Decades-Old Genetic Question
A deep dive into the Novartis HORIZON trial for pelacarsen, an RNA-based medicine aiming to neutralize Lipoprotein(a), a major genetic driver of heart disease.
health -
A New Era in Transplant Medicine Nears Approval
An analysis of the first T-regulatory cell therapy nearing FDA approval, a treatment designed to prevent graft-versus-host disease in bone marrow transplants.
health